0001415889-24-003009.txt : 20240208
0001415889-24-003009.hdr.sgml : 20240208
20240208164257
ACCESSION NUMBER: 0001415889-24-003009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240206
FILED AS OF DATE: 20240208
DATE AS OF CHANGE: 20240208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arroyo Santiago
CENTRAL INDEX KEY: 0001706857
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38916
FILM NUMBER: 24609769
MAIL ADDRESS:
STREET 1: C/O MOMENTA PHARMACEUTICALS, INC.
STREET 2: 675 WEST KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BICYCLE THERAPEUTICS plc
CENTRAL INDEX KEY: 0001761612
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: BLOCKS A & B, PORTWAY BUILDING
STREET 2: GRANTA PARK, GREAT ABINGTON
CITY: CAMBRIDGE
STATE: X0
ZIP: CB21 6GS
BUSINESS PHONE: 011441223261503
MAIL ADDRESS:
STREET 1: BLOCKS A & B, PORTWAY BUILDING
STREET 2: GRANTA PARK, GREAT ABINGTON
CITY: CAMBRIDGE
STATE: X0
ZIP: CB21 6GS
FORMER COMPANY:
FORMER CONFORMED NAME: BICYCLE THERAPEUTICS Ltd
DATE OF NAME CHANGE: 20181212
4
1
form4-02082024_090249.xml
X0508
4
2024-02-06
0001761612
BICYCLE THERAPEUTICS plc
BCYC
0001706857
Arroyo Santiago
C/O BICYCLE THERAPEUTICS PLC
BLOCKS A & B, PORTWAY BUILDING
CAMBRIDGE
X0
CB21 6GS
UNITED KINGDOM
false
true
false
false
CHIEF DEVELOPMENT OFFICER
0
Ordinary Shares
2024-02-06
4
A
0
21660
0
A
39000
D
Employee Stock Option (right to buy)
17
2024-02-06
4
A
0
41570
0
A
2034-02-06
Ordinary Shares
41570
41570
D
Represents a restricted stock unit ("RSU") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2025 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter.
Each RSU represents a contingent right to receive one ordinary share.
This option shall vest one-fourth (1/4) of the total number of shares underlying the option on January 2, 2025 and the remaining shares in 36 equal monthly installments thereafter.
/s/ Jason Minio, Attorney-in-Fact
2024-02-08